The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for ‘reducing fatigue severity and improving quality of life in people with long COVID.’
From this RSS feed
You must log in or # to comment.
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for ‘reducing fatigue severity and improving quality of life in people with long COVID.’
From this RSS feed